Concepedia

Eleanor G. Zuhowski

EG

Statistics

Publications

38

Citations

2.6K

H-Index

26

Active since

1983

Affiliations

University of Maryland, Baltimore(Current)

University of Maryland Medical Center

UPMC Hillman Cancer Center

University of Pittsburgh

National Cancer Institute

Eleanor G. Zuhowski is an author at University of Maryland, Baltimore specializing in pharmacology, medicine, and pharmacokinetics.

Publications per year

1983–2008

38

Publications

38

Cisplatin Preferentially Binds Mitochondrial DNA and Voltage-Dependent Anion Channel Protein in the Mitochondrial Membrane of Head and Neck Squamous Cell Carcinoma: Possible Role in Apoptosis

Zejia Yang, Lisa M. Schumaker, Merrill J. Egorin et al. · Clinical Cancer Research · 2006 · 266 citations

Life Sciences, Molecular Biology, Oncology +14

Phase I Pharmacokinetic-Pharmacodynamic Study of 17-(Allylamino)-17-Demethoxygeldanamycin (17AAG, NSC 330507), a Novel Inhibitor of Heat Shock Protein 90, in Patients with Refractory Advanced Cancers

Ramesh K. Ramanathan, Donald L. Trump, Julie L. Eiseman et al. · Clinical Cancer Research · 2005 · 192 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Inhibition of glutathione synthesis reverses Bcl-2-mediated cisplatin resistance.

Charles M. Rudin, Zejia Yang, Lisa M. Schumaker et al. · PubMed · 2003 · 174 citations

Medicine, Oncology, Pharmacology +17

Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) in CD2F1 mice1

Merrill J. Egorin, Eleanor G. Zuhowski, David Rosen et al. · Cancer Chemotherapy and Pharmacology · 2001 · 134 citations

Pharmacy, Pharmacokinetics, Pharmacology +3

Suramin, an Active Drug for Prostate Cancer: Interim Observations in a Phase I Trial

Mario A. Eisenberger, L. M. Reyno, D. I. Jodrell et al. · JNCI Journal of the National Cancer Institute · 1993 · 131 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

1–5 of 38